Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Research
  • Published:

Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study

International Journal of Impotence Research volume 16, pages 350–353 (2004)Cite this article

Abstract

The association between erectile dysfunction (ED) and acute myocardial infarction (AMI) among men was examined in the Integrated Healthcare Information Services National Managed Care Benchmark Database (IHCIS). The IHCIS is a fully de-identified, HIPAA-compliant database and includes complete medical history for more than 17 million managed care lives; data from more than 30 US health plans, covering seven census regions; and patient demographics, including morbidity, age and gender. A total of 12 825 ED patients and an equal number of male patients without ED were included in the retrospective cohort study. Logistic regression analyses were performed to assess the adjusted risk of AMI that accounted for age at ED diagnosis, smoking, obesity and medications including ACE inhibitors, beta blockers and statins. The cohort of men with ED were observed to have a two-fold increase in the risk for AMI (OR=1.99, 95% CI=1.17, 3.38) after adjusting for age at ED diagnosis, smoking, obesity, and use of ACE inhibitors, beta blockers and statins. Some evidence of a possible trend toward increased risk was detected by age group. After controlling for the aforementioned covariates and compared to men 30–39 y of age, it was noted that patients 40–44 y of age were 3.8 times more likely to develop an AMI (OR=3.76, 95% CI=1.21, 11.7), 45- to 49-y-old men were also more than three times as likely to have an AMI (OR=3.14, 95% CI=1.03, 9.64), and 50- to 55-y-old patients had a four-fold increased risk of developing AMI (OR=4.04, 95% CI=1.39, 11.7). The risk becomes more pronounced with increasing age, indicating the need for cardiologists and internists to monitor ED patients who may not necessarily present with cardiovascular symptoms.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Benet AE, Melman A . The epidemiology of erectile dysfunction. Urol Clin N Am 1995; 22: 699–709.

    CAS  Google Scholar 

  2. Bartolotti A, Parazzini F, Colli E, Landoni M . The epidemiology of erectile dysfunction and its risk factors. Int J Androl 1997; 20: 323–334.

    Article  Google Scholar 

  3. Khan MA et al. Second Consensus Conference on Cardiovascular Risk Factors and Erectile Dysfunction. Curr Med Res Opin 2002; 18: 33–35.

    Article  CAS  Google Scholar 

  4. O'Kane PD, Jackson G . Erectile dysfunction: is there silent obstructive coronary artery disease? Int J Clin Pract 2001; 55: 219–220.

    CAS  PubMed  Google Scholar 

  5. Solomon H, Man JW, Jackson G . Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2003; 89: 251–253.

    Article  CAS  Google Scholar 

  6. Jackson G . Erectile dysfunction and cardiovascular disease. Int J Clin Pract 1999; 53: 363–368.

    CAS  PubMed  Google Scholar 

  7. Kirby M, Jackson G, Betteridge J, Friedli K . Is erectile dysfunction a marker for cardiovascular disease? Int J Clin Pract 2001; 55: 614–618.

    CAS  Google Scholar 

  8. Solomon H et al. Erectile dysfunction: cardiovascular risk and the role of the cardiologist. Int J Clin Pract 2003; 57: 96–99.

    CAS  PubMed  Google Scholar 

  9. Sullivan ME, Keoghane SR, Miller MA . Vascular risk factors and erectile dysfunction. BJU Int 2001; 87: 838–845.

    Article  CAS  Google Scholar 

  10. Virag R, Bouilly P, Frydman D . Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1985; 1: 181–184.

    Article  CAS  Google Scholar 

  11. Feldman HA et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts Male Aging Study. Prev Med 2000; 30: 328–338.

    Article  CAS  Google Scholar 

  12. Feldman HA et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.

    Article  CAS  Google Scholar 

  13. Sullivan ME et al. Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res 1999; 43: 658–665.

    Article  CAS  Google Scholar 

  14. Muller SC, el-Damanhoury H, Ruth J, Lue TF . Hypertension and impotence. Eur Urol 1991; 19: 29–34.

    Article  CAS  Google Scholar 

  15. Burchardt M et al. Erectile dysfunction is a marker for cardiovascular complications and psychological functioning in men with hypertension. Int J Impot Res 2001; 13: 276–281.

    Article  CAS  Google Scholar 

  16. Burchardt M et al. Hypertension is associated with severe erectile dysfunction. J Urol 2000; 164: 1188–1191.

    Article  CAS  Google Scholar 

  17. Greenstein A et al. Does severity of ischemic coronary disease correlate with erectile function? Int J Impot Res 1997; 9: 123–126.

    Article  CAS  Google Scholar 

  18. Wei M et al. Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol 1994; 140: 930–937.

    Article  CAS  Google Scholar 

  19. Murray CJL, Lopez AD . Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 1997; 349: 1498–1504.

    Article  CAS  Google Scholar 

  20. American Heart Association. 2003 Heart and Stroke Statistical Update. American Heart Association: Dallas, TX, 2002.

  21. Probstfield JL . How cost-effective are new preventive strategies for cardiovascular disease? Am J Cardiol 2003; 91: 22G–27G.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Worldwide Epidemiology, GlaxoSmithKline Pharmaceuticals, Collegeville, Pennsylvania, USA

    W A Blumentals, A Gomez-Caminero & S Joo

  2. Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA

    V Vannappagari

Authors
  1. W A Blumentals
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Gomez-Caminero
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Joo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V Vannappagari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W A Blumentals.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blumentals, W., Gomez-Caminero, A., Joo, S. et al. Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study. Int J Impot Res 16, 350–353 (2004). https://doi.org/10.1038/sj.ijir.3901174

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901174

This article is cited by

Search

Advanced search

Quick links